Lisa Dalton - Jul 28, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Director
Signature
/s/ Robert Crotty, by power of attorney
Stock symbol
NBRV
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
4
Date filed
7/30/2021, 08:17 PM
Previous filing
Jun 4, 2021
Next filing
Aug 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Award $0 +17.5K $0.00 17.5K Jul 28, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Options Award $0 +35.5K $0.00 35.5K Jul 28, 2021 Ordinary Shares 35.5K $1.08 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
F2 The option was granted on July 28, 2021.
F3 One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.